A human T-cell line, MOLT-4, either uninfected or infected with murine retroviruses, was tested for its susceptibility to hepatitis -C virus (HCV) infection. The cell cultures were inoculated with a serum containin HCV and then examined for the presence of viral sequences by cDNA/PCR. In murine retrovirus-infected MOLT-4 (MOLT-4 Ma) cells, intracellular minus-strand viral RNA, a putative replication intermediate, was first detected 3 days after inoculation, and the maximum signal was seen on day 7. When the cells were continuously subcultured in fresh medium, HCV sequences were intermittently detected in cells over a period of 3 weeks. In MOLT-4 cells free of retroviruses, replication of minus-strand HCV RNA appeared less efficient than in MOLT-4 Ma cells. The presence of minus-strand viral RNA in MOLT-4 Ma cells inoculated with HCV was confirmed by in situ hybridization with a strand-specific RNA probe. Immunofluorescence tests with antibodies specific for HCV core and NS4 antigeus showed that MOLT-4 Ma cells were positive for viral antigen 7 days after inoculation. Thus, it appears likely that the HCV genome can replicate in the human T-cell line MOLT-4.
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The genome of hepatitis C virus (HCV), the major cause of transfusion-associated non-A, non-B hepatitis, has been cloned (1) . The virion was demonstrated by hybridization analysis to contain a plus-strand RNA of 10 kilonucleotides (2) , and comparative sequence analysis indicated that the virus is distantly related to the flaviviruses and pestiviruses (3, 4) . Synthesis of cDNA by reverse transcription of viral RNA and amplification by PCR with primers based on the nucleotide sequences of HCV cDNA clones have been useful for detecting the HCV genome (5) . Immunodiagnostic assays for antibodies against HCV proteins have also been developed (6) . The studies with chimpanzees have provided evidence that the virus is probably enveloped (7) and is -30-60 nm in diameter (8) . Additional research, however, has been hampered because of the limited availability of chimpanzees and the relatively low titer of virus in clinical samples. To date, little is known about the replication and pathogenesis of this virus, and the virion has not yet been visualized with certainty. The development of in vitro systems for propagating HCV may be critical for the solution to these problems. Specifically, an in vitro system that would permit the development of an assay for virus infectivity remains a pressing need. Applying the recently developed assays for detecting the virus, we initially studied established liver cell lines for their ability to support HCV replication, but these attempts were unsuccessful. Previously, Hellings et al. (9, 10) reported the transmission of non-A, non-B hepatitis (presumably hepatitis C) to chimpanzees that were inoculated with leukocytes, most probably T lymphocytes, derived from either acutely or chronically infected patients or chimpanzees. In addition, the lactate dehydrogenase-elevating virus, another unclassified enveloped RNA virus, has recently been found to replicate more efficiently in mouse cells when they are superinfected with murine leukemia virus (11) . Stimulated by these observations, we tested a human T-cell line, MOLT-4, either uninfected or infected with murine retroviruses, for its ability to support HCV replication. In this report, we describe the detection of minus-strand HCV RNA, believed to be involved in the replication of the viral genome, by cDNA/ PCR, and viral antigens by immunofluorescence in MOLT-4 Ma cells inoculated with serum or plasma containing the virus.
MATERIALS AND METHODS Inoculum. The principal inoculum was a serum obtained from a chimpanzee (Pan troglodytes) infected with the fifth chimpanzee passage of the F strain (12) of HCV. The serum was taken 8 weeks after inoculation, which was 5 weeks after the first detection of characteristic hepatic changes (13) .
In some experiments, human plasma H, containing 1065 50o chimpanzee infectious doses (CID50) per ml of HCV (12) Nucleic acids present in 100 /xl of HCV-containing serum or normal serum were also processed. Liver RNA was isolated by the guanidinium thiocyanate/cesium chloride method (16) .
Whole nucleic acids extracted from serum or cells were used for cDNA synthesis and subsequent double PCR employing nested primers, as described by Kaneko et al. (17) . After cDNA synthesis, the reaction mixture was diluted with H20, boiled for 5 min, cooled on ice, and incubated with 0.1 ,ug of RNase A at 370C for 30 min to remove the residual RNA. The cDNA was then amplified in an automatic thermocycler. Specificity of the amplified DNA was confirmed by Southern blot hybridization with a 32P-labeled synthetic 40-mer oligonucleotide probe internal to PCR primers. The design of the primers was based on published nucleotide sequences of HCV cDNA (18, 19) . Two sets of nested primers were used in the cDNA/PCR for the detection of HCV sequences; one was designed to detect the 5' noncoding region ofthe genome and the other to detect the putative NS5 region. Sequences, polarity and locations, relative to the HCV genome, of 20-mer oligonucleotide primers are shown in Fig. 1 . In the reverse transcription step, sense primer 1 or 5 was used to prime cDNA synthesis from minus-strand HCV RNA, and antisense primer 4 or 8 was used to prime cDNA synthesis from plus-strand RNA. For PCR, external primer pairs 1/4 and 5/8 were used, followed by internal primer pairs 2/3 and 6/7, respectively.
Control Thus, if a minus strand were "detected" solely by an inadvertent amplification from a plus-strand, the plus-strand would have had to be detected at least in 104-to 105-fold excess. The reverse transcriptase activity of Taq DNA polymerase reported (22) was not detected in our assays because there was no measurable amplification when the reverse transcriptase was omitted. Detection of HCV Genomes in Chimpanzee Livers. As shown in Fig. 2A , both plus-and minus-strand RNAs were detected by the cDNA/PCR assay by using the primer pairs 5/8 and 6/7, respectively (refer to Fig. 1 ) in liver tissues from chimpanzees 177, 85, and 55 infected with HCV but were not detected in liver from uninfected chimpanzee 56. Specificity of the bands was confirmed by Southern blot hybridization using a 32P-labeled 40-mer oligonucleotide (probe 10) (Fig.  2B) . Comparable results were obtained with primer pairs 1/4 and 2/3. To determine the relative titers of plus-and minusstrand viral RNA in HCV-infected livers, 10-fold dilutions of -0.5 jug of cytoplasmic total RNA extracted from livers of infected chimpanzees 177, 85, and 55 were examined for each strand. Fig. 2C shows that the ratio ofplus-and minus-strand HCV RNA appeared to be 1:1 for 177 and 10:1 for 85 and 55. These results generally agreed with the less quantitative results depicted in Fig. 2 A and B , except for chimpanzee 55.
Infection of MOLT-4 Cells with HCV. To examine the susceptibility of MOLT-4 and MOLT-4 Ma cells to HCV infection, cells were inoculated with HCV and cultured without medium changes for 7 days. The inoculum contained 103 genomes per 100 ulI of plus-strand viral RNA by PCR, but minus-strand was not detected (Fig. 2) . Cell suspensions harvested on days 1, 3, 5, and 7 were examined for intracellular minus-strand viral RNA by cDNA/PCR by using sense primer 5 for reverse transcription and primer pairs 5/8 and 6/7 for PCR. In the infected MOLT-4 Ma cells, minus-strand RNA was first detected on the third day of culture and increased to the maximum level on day 7. In similarly infected MOLT-4 cells, minus-strand viral RNA was first detected 7 days after inoculation (Fig. 3) .
Because MOLT-4 Ma cells yielded stronger signals for minus-strand viral RNA, we chose them for additional experiments in which inoculated cells were maintained for =4 weeks by subculture at 3-day to 4-day intervals. The results are summarized in Table 1 . Intracellular minus-strand viral RNA could not be detected during the first 4 days, but it was detected 6-9 days after inoculation. Both plus-and minusstrand HCV sequences were detected in the cells sporadically A B thereafter for 2-3 weeks. Viral sequences were also detected sporadically in the supernatants of the cultures from day-8 to day-14 postinoculation.
To determine whether the occasional disappearance of HCV sequences in the cells during subcultures was related to the state of cell growth, MOLT-4 Ma cells were harvested 14 days after inoculation, washed once, diluted to 2 x 105 cells per ml with fresh medium, distributed into culture bottles, and subcultured without changing the medium for 7 days. The cells were examined daily for cell growth, and a pellet of =1 Table 1 x 106 cells was tested for HCV sequences. Fig. 4 demonstrates the kinetics of cell growth and the detection of intracellular HCV minus-strand RNA by cDNA/PCR 5 days after subculture. Both plus-and minus-strand HCV RNAs had titers of 100 genomes per cell pellet by PCR at this time. To confirm these observations, in situ hybridization, using a 35S-labeled HCV plus-strand RNA probe, was used on MOLT4 Ma cells harvested 7 days after virus inoculation in another experiment. Fig. 5A shows that minus-strand HCV RNA was detected in the infected MOLT-4 Ma cells; about 1% of the cells were positive. Uninoculated MOLT-4 Ma cells were negative for HCV RNA when hybridized with the probe (Fig. SB) .
To test for expression of virus-encoded proteins, the cells were examined for putative HCV core and NS4 antigens by the indirect immunofluorescence method with mouse monoclonal antibodies. MOLT4 Ma cells were found positive for both viral antigens 7 days after inoculation ( Fig. 6 A and B) ; about 1% of the cells were positive for both antigens. Uninoculated cells were negative (Fig. 6 C and D) .
Selected experiments were repeated with the wellcharacterized H-strain of HCV (12) . A 2.25-ml sample of cell suspension containing 1.5 x 106 MOLT-4 Ma cells was inoculated with 0.25 ml of plasma containing HCV, strain H. In this experiment fresh MOLT4 Ma cells were added to the cultures at 2-to 5-day intervals in an attempt to maintain the positive cultures longer. As shown in Fig. 7 , intracellular minus-strand viral RNA was detected on day 1 and again after possible, based on the PCR data, to discriminate among (i) inadvertant amplification of plus-strand during PCR, (ii) carry-over of preexisting minus-strand from the inoculum, or (iii) viral replication as the source of the minus-strand signal in cells inoculated with the H strain of HCV. Minus-strand was also detected by Fong et al. (23) in this same HCVcontaining plasma. However, in the present study, the positive signal on day 1 disappeared and did not reappear until after 7 days in culture, suggesting that actual HCV replication took place.
DISCUSSION
Shortly after infection of cells with positive-strand RNA viruses, minus-strand RNA is transcribed from the genomic RNA, and this minus-strand becomes the template for the synthesis of progeny plus-strand RNAs. Although the mode of HCV replication is not fully understood, minus-strand HCV RNA would be expected to be present in the cells when active viral replication occurs. Thus, in the present study, HCV replication in MOLT-4 and MOLT-4 Ma cells was evaluated primarily by detection ofintracellular minus-strand replicative intermediates. The data suggest that the HCV genome replicated in both MOLT-4 and MOLT-4 Ma cells, as detected by demonstration of intracellular minus-strand viral RNA by cDNA/PCR. It was unlikely that HCV sequences detected in the infected cultures were derived from the inoculum for the following reasons: (i) intracellular minusstrand HCV RNA was not detected during the first 1-5 days of culture, and the intensity of the signals increased with time; if the signal had been due to carry-over, the signal should have been progressively lost. (ii) In the principal inoculum used in this study, minus-strand could not be detected. (iii) HCV RNA was detected in the cells for a period spanning 24 days after inoculation. In the culture supernatants, viral RNA remained detectable up to 14 days (Table 1) . During the 24 days of culture the cells multiplied with a doubling of 24 hr to attain a 107-fold increase, and on day 14 the culture medium had been diluted -1010-fold by centrifugation/resuspension steps during subcultures. Thus, carryover HCV RNA from the inoculum (103 genomes per 100 p.l by PCR) should have been diluted 104-fold and 107-fold beyond the estimated titers of residual genomes in the cells (day 24) and supernatant (day 14), respectively. (iv) Had the detection of minus-strand in the infected cells been caused by the nonspecific amplification of plus-strand from the inoculum, we should have detected plus-strand in 104-fold excess, based on the experiments described above; this actually was not the case. In the experiment shown in Fig. 4 , the PCR titers of plus-and minus-strands were both 100 genomes per cell pellet and, as shown in Table 1 , the minus-strand could be detected even when the positive-strand was undetectable. (v) We demonstrated intracellular HCV minus-strand by in situ hybridization with a strand-specific probe, using a modification of a technique recently shown to be specific for HCV sequences in infected hepatocytes (24) . (vi) We demonstrated viral core and NS4 antigens by immunofluorescence with monoclonal antibodies from two different sources. Taken together, these findings strongly suggest that the HCV genome replicates and expresses viral gene products in MOLT-4 Ma cells.
Although being essentially hepatotropic, a lymphotropic character of HCV has been suggested by the data of Hellings et al. (9, 10) . They demonstrated the transmission of presumed hepatitis C to chimpanzees by leucocyte preparations from a human patient and from an infected chimpanzee. Our present results are consistent with these findings.
The present data suggest that HCV is able to replicate in a human T-cell line. Establishment of in vitro systems for propagation of HCV will be valuable for further characterization of this virus and for development of in vitro assays of virus infectivity, virus neutralization, etc.
